UK to set up chlamydia screening programme:
This article was originally published in Clinica
Executive Summary
The UK government is considering implementing a national screening programme for chlamydia. It will carry out a feasibility study on the programme later this year in two pilot areas. The move comes as part of a drive to stem the increased incidence of the disease, which can cause pelvic inflammation disease which in turn can lead to sterility. A urine-based test to detect the disease will be offered to sexually active women under the age of 25 and older women who have more than one partner in a year. If a women is found to have the disease, her partner will also be offered the test.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.